A phase Ib/II trial testing famitinib added to dalpiciclib and fulvestrant in HR-positive, HER2-negative advanced breast ...
A 2026 review proposes that SFRP4 may inhibit tumor angiogenesis through integrin-linked disruption of Wnt–β-catenin ...
OncoC4 Inc., a late clinical-stage biopharmaceutical company developing novel medicines for cancer and neurodegenerative ...
Arcus Biosciences casdatifan combinations showed superior or competitive PFS and response rates versus historical benchmarks.
PD-1 bispecific antibodies combine checkpoint blockade with CTLA-4 or VEGF targeting. Can one engineered molecule offer ...
CROWN ctDNA data link early lorlatinib progression to genomic complexity, TP53 and bypass pathways rather than new ALK ...
EyePoint thanks its employees affected by these measures for their dedication and contributions to the Company’s mission. Although today’s clinical setback highlights the challenges of drug ...
Not everyone with kidney cancer will experience all of these symptoms. Only 10 percent to 15 percent of patients have the “ ...
Which fruits may help prevent cancer? Doctor explains fruits like berries, apples, kiwis and more can lower cancer risk by ...
LUCIA did not achieve the primary endpoint of statistical non-inferiority in mean change in BCVA versus on-label aflibercept control, despite demonstrating visual improvement – – Key secondary ...
An experimental treatment containing two naturally occurring pancreatic enzymes may be able to reduce the growth of cancer, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results